Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancerFabio Barra, Simone Ferrero, Franco De Cian et al.|Expert Opinion on Investigational Drugs|2018Cited by 102
Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosisFabio Barra, Simone Ferrero, Lorenzo Ferro Desideri|British Journal of Pharmacology|2018Cited by 33
Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degenerationLorenzo Ferro Desideri, Massimo Nicolò, Carlo Enrico Traverso et al.|Expert Opinion on Biological Therapy|2019Cited by 26